Tweedy Browne's BMY Position Overview
Tweedy Browne (via Tweedy, Browne Co LLC) currently holds 16,842 shares of Bristol-Myers Squibb Company (BMY) worth $908,457, representing 0.07% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Tweedy Browne has maintained this position in BMY for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 7,282 shares.
Analysis based on 13F filings available since 2013 Q2
Tweedy Browne's Bristol-Myers Squibb Company (BMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bristol-Myers Squibb Company (BMY) Trades by Tweedy Browne
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2025 | +7,184 | New Buy | 7,184 | $46.29 |
| Q3 2025 | +7,282 | Add 101.36% | 14,466 | $45.10 |
| Q4 2025 | +2,376 | Add 16.42% | 16,842 | $53.94 |
Tweedy Browne's Bristol-Myers Squibb Company Investment FAQs
Tweedy Browne first purchased Bristol-Myers Squibb Company (BMY) in Q2 2025, acquiring 7,184 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Tweedy Browne has held Bristol-Myers Squibb Company (BMY) for 3 quarters since Q2 2025.
Tweedy Browne's largest addition to Bristol-Myers Squibb Company (BMY) was in Q3 2025, adding 14,466 shares worth $652,417.
According to the latest 13F filing for Q4 2025, Tweedy Browne's firm, Tweedy, Browne Co LLC, owns 16,842 shares of Bristol-Myers Squibb Company (BMY), valued at approximately $908,457.
As of the Q4 2025 filing, Bristol-Myers Squibb Company (BMY) represents approximately 0.07% of Tweedy Browne's publicly disclosed stock portfolio, making it one of their key holdings.
Tweedy Browne's peak holding in Bristol-Myers Squibb Company (BMY) was 16,842 shares, as reported at the end of Q4 2025.